0
0

Discounted Drugs for Clinical Trials Act

12/29/2022, 11:48 PM

Congressional Summary of S 4053

Discounted Drugs for Clinical Trials Act

This bill allows researchers to obtain certain high-cost drugs and biologics at discounted prices from manufacturers. Researchers must apply to the Food and Drug Administration for approval; manufacturers must sell the approved quantity of drugs to researchers at the discounted price and are subject to civil actions from researchers for noncompliance.

Current Status of Bill S 4053

Bill S 4053 is currently in the status of Bill Introduced since April 7, 2022. Bill S 4053 was introduced during Congress 117 and was introduced to the Senate on April 7, 2022.  Bill S 4053's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of April 7, 2022

Bipartisan Support of Bill S 4053

Total Number of Sponsors
1
Democrat Sponsors
1
Republican Sponsors
0
Unaffiliated Sponsors
0
Total Number of Cosponsors
1
Democrat Cosponsors
1
Republican Cosponsors
0
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill S 4053

Primary Policy Focus

Health

Alternate Title(s) of Bill S 4053

Discounted Drugs for Clinical Trials Act
Discounted Drugs for Clinical Trials Act
A bill to amend the Federal Food, Drug, and Cosmetic Act to grant eligible researchers access to eligible products at a discounted price for qualified research, and for other purposes.

Comments